D. Bugarski et al., Effects of treatment with interleukin-1 receptor antagonist on endogenous interleukin-1 levels in normal and irradiated mice, PHYSL RES, 49(3), 2000, pp. 355-362
The in vivo effects of recombinant human interleukin-1 receptor antagonist
(rhIL-1Ra) administration on endogenous IL-1 levels in the circulation and
conditioned media (CM) from different immunohematopoietic organ/tissues wer
e studied in CBA mice under steady state and postirradiation conditions. In
normal mice, constitutive IL-1 levels were demonstrated in the plasma, CM
of peritoneal exudate cells and full-thickness skin explants with low or un
detectable levels in CM of splenic and bone marrow cell suspensions. In irr
adiated mice (2 Gy, X rays) on day 3 post exposure a significant increase o
f IL-1 levels was seen in the circulation and CM of peritoneal exudate cell
s, with no significantly different levels in postirradiation bone marrow, s
pleen and skin. After rhIL-1Ra treatment of the animals (2 x 50 mu g/mouse,
i.p.), significantly elevated IL-1 levels were observed in the skin and CM
of peritoneal exudate cells in normal mice, whereas slightly increased lev
els were detected in CM of splenic cells. The rhIL-1Ra administration in ir
radiated mice led to decreased IL-1 concentrations in the circulation, and
CM of peritoneal exudate cells and skin. The results pointed out the import
ance of IL-1 secretion and receptor expression in the maintenance of homeos
tasis in steady state, as well as during recovery after irradiation. Modula
tory effects of IL-1Ra on IL-1 production were dependent on basic endogenou
s IL-1 concentration.